Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, reasonably
Target Price
The average target price of AZT.OL is 31 and suggests 48% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
Buy
Sell